Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
about
O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsRecent advancements in multimodality treatment of gliomasInitial treatment patterns over time for anaplastic oligodendroglial tumors.International retrospective study of over 1000 adults with anaplastic oligodendroglial tumorsOncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse modelA phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumorsMedical therapy of gliomas.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).The future of high-grade glioma: Where we are and where are we going.Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCRPhase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.Low-grade oligodendroglioma: current treatments and future hopes.Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.Anaplastic glioma: current treatment and management.Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?Radiological features of supratentorial gliomas are associated with their genetic aberrations.Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.Success at last: a molecular factor that informs treatment.Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.Recent innovations in the management of low-grade gliomas.
P2860
Q26853112-7B07616C-31AB-4876-883C-ECAE4442A1F1Q27001724-A524B4A5-2EC2-4E58-9946-3768A8FDD7EFQ30419123-CD2CB902-1B59-45B4-A8BA-03D9D0B4C746Q30426724-00D40271-0C92-4023-8E96-BA908CF41218Q33579323-7E4131A1-34D5-4B16-ABCB-7555DCB8A3F7Q34132883-AC73CD17-C377-466A-9BC7-07285CCEA0A3Q34218761-FB5D8ED4-B577-4DE8-8F49-39A8A4E87C74Q34478948-602AAF91-9B61-4A35-B1DF-107562088279Q35114090-DADE8909-C265-42E5-A3A7-C0255E5A0B25Q35633835-AA0C2DE9-1E95-4EC2-8459-6E5946F28656Q35850389-AAE46723-961C-4931-BFA1-E42B21CC5808Q36096036-2BCA5044-FB89-46C7-A8C1-73000345F4F6Q37377386-B5A7BCB1-982E-4C41-A963-30C39679109EQ37628706-7FA636F5-6D3A-4EB0-81BF-041957E1501FQ38298229-01A2B648-BA4B-4053-AED1-FA1961D0DCA4Q38456018-E1DF5311-F1A8-43F3-8CE4-3EECB22998F3Q38481449-D7C78CEA-0649-4049-9952-88BCF7CEFE3BQ38518831-BE7DA95C-8969-4F42-8B60-768C6AC3AABFQ38626948-9EAEC87A-0183-473E-B44F-A51FE59C3F0EQ44541218-BE5C922F-1704-4389-AA8C-32146788B9C5Q46071407-100BA5EC-969D-459B-8EB4-04AAB37F388DQ48250296-612752DE-9576-4EF1-A7E0-4EB3CF117034Q48457980-72BE475F-E133-447A-9576-ED6127561343Q48910170-49131CCC-0616-4C69-B33A-70A065D0F1AEQ55462054-65227C77-D240-47A2-A1C9-B0A2942C50D1
P2860
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II trial of preirradiati ...... oligoastrocytomas: RTOG BR0131
@en
Phase II trial of preirradiati ...... ligoastrocytomas: RTOG BR0131.
@nl
type
label
Phase II trial of preirradiati ...... oligoastrocytomas: RTOG BR0131
@en
Phase II trial of preirradiati ...... ligoastrocytomas: RTOG BR0131.
@nl
prefLabel
Phase II trial of preirradiati ...... oligoastrocytomas: RTOG BR0131
@en
Phase II trial of preirradiati ...... ligoastrocytomas: RTOG BR0131.
@nl
P2093
P2860
P921
P1433
P1476
Phase II trial of preirradiati ...... oligoastrocytomas: RTOG BR0131
@en
P2093
Brian Berkey
Caterina Giannini
Christopher Biggs
Christopher Schultz
David Macdonald
David Peereboom
Deborah T Blumenthal
James Herman
John H Suh
Michael A Vogelbaum
P2860
P304
P356
10.1215/15228517-2008-073
P50
P577
2008-09-08T00:00:00Z